Retrospective analysis of antimicrobial resistance and bacterial spectrum of infection in Gabon, Central Africa

BMC Infectious Diseases

Table 4 Non-susceptibility rates of the most prevalent bacterial pathogens from bloodstream infections in Gabon

Pathogen (n)	Antimicrobial non-susceptibility (%)
Pathogen (n)	PEN/AMP^a	COX	AMP + BLI	CRO	GEN	CIP	CHL	CLI	ERY	SXT	TCY
S. aureus (30)	89.7	0	0	0	0	0	0	0	10	7.8	66.7
S. pyogenes (3)	0	-	-	0	-	-	ND	0	0	0	-
S. pneumoniae (15)	25	-	-	25	-	-	33.3	14.3	13.3	71.4	ND
K. pneumoniae (29)	100	-	92.6	74.1	75	37.9	100	-	-	96.3	ND
P. agglomerans (11)	90.9	-	81.8	80	45.4	18.2	50	-	-	80	ND
E. coli (16)	81.2	-	62.5	0	6.3	12.5	66.7	-	-	81.2	ND
S. enterica (26)	3.9	-	3.9	3.9	0	0	11.1	-	-	4	0

Note: Abbrevations are penicillin/ampicillin (PEN/AMP), cefoxitin (COX), ampicillin plus betalactamase-inhibitor (AMP + BLI), ceftriaxone (CRO), gentamicin (GEN), ciprofloxacin (CIP), chloramphenicol (CHL), clindamycin (CLI), erythromycin (ERY), cotrimoxazole (SXT), tetracycline (TCY), not done (ND). Non-susceptible isolates are shown as the percentage of tested isolates. Data from P. aeruginosa and P. mirabilis were not reported due to small sample size (n = 2).
^aShown is the non-susceptibility of Gram-positives to penicillin and the non-susceptibility of Gram-negatives to ampicillin.

ISSN: 1471-2334